SURTAVI
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Public sites
- 56
- Start date
- Apr 1, 2012
Keck Hospital of USC provides heart valve care through the USC Valve Center, with cardiologists and cardiac surgeons treating aortic, mitral, tricuspid and bicuspid valve disease. Care includes surgical and minimally invasive valve repair or replacement, transcatheter aortic valve implantation (TAVI/TAVR), and the Ross procedure, supported by a multidisciplinary team.
This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Screening Survey
Los Angeles, CA
Los Angeles, CA
Los Angeles, CA